Cumulative Risk Assessment for De Novo and Recurrent Nonliver Cancer After Liver Transplantation Based on Pretransplant Cancer Experience

PTM associated post-LT cancer outcomes are dominated by skin and liver cancer recurrence and not recurrence of "other" cancers or de novo cancer. This data supports the guidance proposals for cautious liberalization of "other" cancer remission requirements before transplantation. As post-LT cancer is highly prevalent regardless of PTM status, adherence to posttransplant cancer screening and surveillance is critical to identify early cancer after transplant.